NDC 50458-141

INVOKANA

Canagliflozin

INVOKANA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is Canagliflozin.

• Product ID: 50458-141_035310ca-67f4-11e9-8a7c-5a080199106d
• NDC: 50458-141
• Product Type: Human Prescription Drug
• Proprietary Name: INVOKANA
• Generic Name: Canagliflozin
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2013-03-29
• Marketing Category: NDA / NDA
• Application Number: NDA204042
• Labeler Name: Janssen Pharmaceuticals, Inc.
• Substance Name: CANAGLIFLOZIN
• Active Ingredient Strength: 300 mg/1
• Pharm Classes: Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 50458-141-01

5 TABLET, FILM COATED in 1 BOTTLE (50458-141-01)

• Marketing Start Date: 2013-03-29
• NDC Exclude Flag: N
• Sample Package?: Y

NDC SPL Data Element Entries

NDC 50458-141-30 [50458014130]

INVOKANA TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA204042
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2013-03-29

NDC 50458-141-50 [50458014150]

INVOKANA TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA204042
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2013-03-29

NDC 50458-141-01 [50458014101]

INVOKANA TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA204042
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2013-03-29

NDC 50458-141-90 [50458014190]

INVOKANA TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA204042
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2013-03-29

NDC 50458-141-10 [50458014110]

INVOKANA TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA204042
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2013-03-29

Drug Details

Active Ingredients

Ingredient	Strength
CANAGLIFLOZIN	300 mg/1

OpenFDA Data

• SPL SET ID: b9057d3b-b104-4f09-8a61-c61ef9d4a3f3
• Manufacturer:
  • Janssen Pharmaceuticals, Inc.
• UNII:
  • 0SAC974Z85
• RxNorm Concept Unique ID - RxCUI:
  • 1373463
  • 1373471
  • 1373469
  • 1373473

Pharmacological Class

• Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
• Sodium-Glucose Transporter 2 Inhibitors [MoA]
• P-Glycoprotein Inhibitors [MoA]

Medicade Reported Pricing

50458014190 INVOKANA 300 MG TABLET

Pricing Unit: EA | Drug Type:

50458014130 INVOKANA 300 MG TABLET

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "INVOKANA" or generic name "Canagliflozin"

NDC	Brand Name	Generic Name
50090-4364	INVOKANA	canagliflozin
50090-5029	INVOKANA	canagliflozin
50090-5033	INVOKANA	canagliflozin
50090-5034	INVOKANA	canagliflozin
50458-140	INVOKANA	canagliflozin
50458-141	INVOKANA	canagliflozin
55154-1425	INVOKANA	canagliflozin
55154-1426	INVOKANA	canagliflozin